Kane Biotech Announces new DispersinB® Publication in Pathogens and Conference Presentations

WINNIPEG, Manitoba, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces the publication of a new review article on DispersinB^® in the journal Pathogens.

Read more at globenewswire.com